Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2015-03-24 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a disclosure return related to changes in issued share capital and share buybacks by PW Medtech Group Limited. It includes detailed information about share repurchases, number of shares involved, prices, and compliance with listing rules. The document is regulatory in nature, reporting share repurchase activity rather than announcing a new share issue or capital change event. It is not a full financial report, earnings release, or management discussion. The content fits the category of a Transaction in Own Shares (POS), as it reports on the company's repurchase of its own shares with detailed transactional data and compliance confirmation.
2015-03-24 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2014
Annual Report Classification · 95% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2014' and contains detailed financial highlights such as revenue, gross profit, net profit, earnings per share, and business and market review for the full fiscal year 2014. It discusses business strategies, acquisitions, product portfolio expansion, R&D, distribution network, and production capacity. The length is substantial (15,000 characters), and it contains substantive financial data and analysis for the full fiscal year. This matches the characteristics of an Annual Report (10-K) or an Earnings Release (ER). However, the document is more comprehensive than a brief earnings release, including detailed business review and strategic information, which is typical of an Annual Report. There is no indication that this is merely an announcement of a report or a certification. Therefore, the best classification is Annual Report (10-K). FY 2014
2015-03-22 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 95% confidence The document lists the members of the board of directors and their roles, including executive, non-executive, and independent non-executive directors, as well as the composition of board committees such as the Audit Committee, Remuneration Committee, and Nomination Committee. There is no financial data, no mention of a report or meeting, and no indication of changes in board membership. The content is focused on board and management information, specifically the structure and roles of directors. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and does not indicate an announcement of a report or voting results, so other categories are less appropriate.
2015-03-22 English
CHANGE OF NON-EXECUTIVE DIRECTOR AND REMUNERATION COMMITTEE MEMBER
Board/Management Information Classification · 100% confidence The document is an announcement from PW Medtech Group Limited regarding changes in the company's board of directors, specifically the resignation of a non-executive director and the appointment of a new non-executive director who is also a member of the remuneration committee. The content focuses on management changes and biographical details of the new appointee. There is no financial data, no mention of annual or interim reports, no voting results, and no other regulatory or financial disclosures. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2015-03-22 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding the date of a board meeting to approve the consolidated annual results for the year ended 31 December 2014 and to consider a final dividend. It does not contain the actual annual report or financial results but merely announces the upcoming board meeting where these will be approved and announced. The document is short (1396 characters) and serves as a notice rather than a report itself. According to the 'MENU VS MEAL' rule, this is an announcement about a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2015-03-10 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, PW Medtech Group Limited, reporting changes in issued share capital and share buybacks. It references specific rules from the Hong Kong Stock Exchange Listing Rules (rule 13.25A and rule 10.06(4)(a)) related to disclosures of share capital changes and repurchases. The content includes detailed data on issued shares, repurchased shares, cancellation of repurchased shares, and confirmations regarding compliance with Listing Rules. This type of document is a regulatory disclosure about share capital changes and share buybacks, not a financial report or earnings release. It fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares (share repurchase/issuance). The document length (5900 characters) and detailed data support this classification with high confidence.
2015-03-06 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.